Northern Trust »

Adaptimmune Therapeutics shares owned by Northern Trust

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Northern Trust from 13F filings

Historical chart of Northern Trust investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Northern Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Northern Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.3k 49k 0.13
2025-06-30 $12k 51k 0.24
2025-03-31 $0 51k 0.00
2024-12-31 $51k 51k 1.00
2024-09-30 $49k 51k 0.95
2024-03-31 $91k 58k 1.58
2023-09-30 $45k 57k 0.78
2023-06-30 $54k 59k 0.93
2020-12-31 $270k 50k 5.40